In all seriousness, the combined posts make for a nice summary, and perhaps the best support I've heard (outside the biotech conference) for the the low-dose arms equaling daptomycin. The "truth" will be apparent soon enough...
If the price falls into the 1.70's I will add as much as 25% to my position.